Success Metrics

Clinical Success Rate
88.9%

Based on 8 completed trials

Completion Rate
89%(8/9)
Active Trials
1(9%)
Results Posted
75%(6 trials)
Terminated
1(9%)

Phase Distribution

Ph phase_1
4
36%
Ph not_applicable
5
45%
Ph phase_2
2
18%

Phase Distribution

4

Early Stage

2

Mid Stage

0

Late Stage

Phase Distribution11 total trials
Phase 1Safety & dosage
4(36.4%)
Phase 2Efficacy & side effects
2(18.2%)
N/ANon-phased studies
5(45.5%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

88.9%

8 of 9 finished

Non-Completion Rate

11.1%

1 ended early

Currently Active

1

trials recruiting

Total Trials

11

all time

Status Distribution
Active(1)
Completed(8)
Terminated(1)
Other(1)

Detailed Status

Completed8
Active, not recruiting1
Terminated1
unknown1

Development Timeline

Analytics

Development Status

Total Trials
11
Active
1
Success Rate
88.9%
Most Advanced
Phase 2

Trials by Phase

Phase 14 (36.4%)
Phase 22 (18.2%)
N/A5 (45.5%)

Trials by Status

active_not_recruiting19%
completed873%
terminated19%
unknown19%

Recent Activity

Clinical Trials (11)

Drug Details

Intervention Type
RADIATION
Total Trials
11